PT3491027T - Processo para a preparação e purificação do sal de sódio do ácido hialurónico - Google Patents

Processo para a preparação e purificação do sal de sódio do ácido hialurónico

Info

Publication number
PT3491027T
PT3491027T PT177555711T PT17755571T PT3491027T PT 3491027 T PT3491027 T PT 3491027T PT 177555711 T PT177555711 T PT 177555711T PT 17755571 T PT17755571 T PT 17755571T PT 3491027 T PT3491027 T PT 3491027T
Authority
PT
Portugal
Prior art keywords
purification
preparation
sodium salt
hyaluronic acid
hyaluronic
Prior art date
Application number
PT177555711T
Other languages
English (en)
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of PT3491027T publication Critical patent/PT3491027T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Surgery (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Birds (AREA)
  • Urology & Nephrology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT177555711T 2016-07-28 2017-07-27 Processo para a preparação e purificação do sal de sódio do ácido hialurónico PT3491027T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000079633A IT201600079633A1 (it) 2016-07-28 2016-07-28 Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico

Publications (1)

Publication Number Publication Date
PT3491027T true PT3491027T (pt) 2020-08-24

Family

ID=57610222

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177555711T PT3491027T (pt) 2016-07-28 2017-07-27 Processo para a preparação e purificação do sal de sódio do ácido hialurónico

Country Status (14)

Country Link
US (2) US10849925B2 (pt)
EP (1) EP3491027B1 (pt)
JP (1) JP6980974B2 (pt)
KR (1) KR102391110B1 (pt)
CN (1) CN109563178B (pt)
AU (1) AU2017304290B2 (pt)
CA (1) CA3030243A1 (pt)
EA (1) EA039615B1 (pt)
ES (1) ES2811101T3 (pt)
HU (1) HUE050414T2 (pt)
IT (1) IT201600079633A1 (pt)
PL (1) PL3491027T3 (pt)
PT (1) PT3491027T (pt)
WO (1) WO2018020458A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800009444A1 (it) 2018-10-15 2020-04-15 Fidia Farm Spa Coniugati tra acido ialuronico e amminobisfosfonati e loro impiego terapeutico
IT201800009731A1 (it) 2018-10-25 2020-04-25 Fidia Farm Spa Coniugato paclitaxel - acido ialuronico nel trattamento del carcinoma vescicale non infiltrante
IT201900019762A1 (it) 2019-10-24 2021-04-24 Fidia Farm Spa Composizione farmaceutica per uso nel trattamento della cistite di varia eziologia
IT202000005692A1 (it) 2020-03-17 2021-09-17 Fidia Farm Spa Bio-inchiostro per stampa 3D, relativo coniugato e processo di preparazione di un intermedio costituito da un linker fotoreattivo
IT202000007747A1 (it) 2020-04-10 2021-10-10 Fidia Farm Spa Coniugato acido ialuronico-paclitaxel nel trattamento del mesotelioma
IT202000008209A1 (it) 2020-04-17 2021-10-17 Fidia Farm Spa Procedimento di sintesi di un coniugato acido ialuronico-paclitaxel
IT202000014017A1 (it) 2020-06-11 2021-12-11 Fidia Farm Spa Nuovi derivati ottenuti da acido ialuronico e carnosina
IT202000032243A1 (it) 2020-12-23 2022-06-23 Fidia Farm Spa Nuovi agenti antivirali
CN112940148A (zh) * 2021-04-06 2021-06-11 山东众山生物科技有限公司 一种透明质酸的纯化方法
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo
CN114805636B (zh) * 2022-05-26 2023-08-04 宁夏华吉生物有限公司 一种制备透明质酸钠的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780414A (en) * 1985-01-18 1988-10-25 Bio-Technology General Corp. Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
JP2587268B2 (ja) * 1988-04-18 1997-03-05 チッソ株式会社 低粘度ヒアルロン酸又はその塩の製造方法
CA2061566C (en) * 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
IT1263393B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
US6660853B2 (en) * 2000-12-15 2003-12-09 Al Prescott Method for purifying high molecular weight hyaluronic acid
CA2491054A1 (en) * 2002-07-03 2004-01-15 Pericor Science, Inc. Compositions of hyaluronic acid and methods of use
AU2003252566A1 (en) * 2002-08-19 2004-03-03 Kolon Ind. Inc. Microorganism producing hyaluronic acid and purification method of hyaluronic acid
FR2861734B1 (fr) * 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
CN1259345C (zh) * 2004-08-10 2006-06-14 江南大学 一种从透明质酸发酵液中制备透明质酸钠的方法
KR20120077726A (ko) * 2010-12-31 2012-07-10 코오롱생명과학 주식회사 히알루론산 및 그 염의 정제방법
ITMI20121184A1 (it) * 2012-07-05 2014-01-06 Altergon Italia Srl Processo per la produzione industriale di ialuronato di sodio (hana) altamente purificato a peso molecolare controllato
KR101447975B1 (ko) * 2013-03-25 2014-10-13 한국식품연구원 초음파를 이용한 히알루론산 추출 방법
CN103304684B (zh) * 2013-06-28 2015-07-15 四川柯森油田化学有限公司 一种提取纯化透明质酸的生产方法

Also Published As

Publication number Publication date
JP6980974B2 (ja) 2021-12-15
US11395833B2 (en) 2022-07-26
AU2017304290A1 (en) 2019-01-24
KR102391110B1 (ko) 2022-04-26
CN109563178B (zh) 2021-12-28
PL3491027T3 (pl) 2020-11-16
US20190224232A1 (en) 2019-07-25
US10849925B2 (en) 2020-12-01
HUE050414T2 (hu) 2020-12-28
EP3491027B1 (en) 2020-07-01
IT201600079633A1 (it) 2018-01-28
CA3030243A1 (en) 2018-02-01
EA039615B1 (ru) 2022-02-17
AU2017304290B2 (en) 2020-10-29
US20210046103A1 (en) 2021-02-18
WO2018020458A1 (en) 2018-02-01
EP3491027A1 (en) 2019-06-05
KR20190039099A (ko) 2019-04-10
CN109563178A (zh) 2019-04-02
EA201990091A1 (ru) 2019-05-31
JP2019528055A (ja) 2019-10-10
ES2811101T3 (es) 2021-03-10

Similar Documents

Publication Publication Date Title
HUE050414T2 (hu) Eljárás hialuronsav nátriumsója elõállítására és tisztítására
ZA201706944B (en) Process for the purification of water
PT3655138T (pt) Processo para a purificação de ácido hialurónico
HK1254055A1 (zh) 製備奧貝膽酸及其衍生物的方法
GB201521581D0 (en) Methods of purifying nanostructures
HUE050782T2 (hu) Eljárás Carboprost és trometamin sójának elõállítására
PL3116514T3 (pl) Koniugaty oligomeru kwasu hialuronowego lub jego soli, sposób ich wytwarzania i ich zastosowanie
HK1250717A1 (zh) 製備乙酰半乳糖胺酸衍生物的方法
SG11201710689TA (en) Process of purifying methionine
HK1220444A1 (zh) 拉喹莫德鈉晶體和用於製造它們的改進方法
HUE063127T2 (hu) Eljárás metilkobalamin tisztítására
PL3271322T3 (pl) Proces oczyszczania kwasu monochloroacetycznego
PL3328523T3 (pl) Sposób odzyskiwania siarczanu sodu
ZA201801991B (en) Process for the preparation of monochloroacetic acid
EP3366641A4 (en) METHOD FOR PRODUCING A CLEANED AQUEOUS SOLUTION OF SILICA
ZA201704637B (en) Process in water for the preparation of butyric esters of hyaluronic acid sodium salt
PT3302409T (pt) Processo e composição para estimular a síntese do ácido hialurónico
EP2997009A4 (en) Process for the preparation of arformoterol or salt thereof
HUE044225T2 (hu) Eljárás akrilsav tisztítására
ZA201708170B (en) Process for the preparation of sodium cyanide
EP3377448A4 (en) Preparation of magnetite from ferrous chloride subsequent to sulphate removal by ion-exchange
HUE056431T2 (hu) Eljárás misoprostol elõállítására és tisztítására
SG11201801065PA (en) An improved process for the preparation of tetrofosmin or acid addition salt thereof
HUE053193T2 (hu) Eljárás megnövelt stabilitású epoprostenol nátrium elõállítására
SI3397630T1 (sl) Postoek za pripravo natrijevega pantoprazolata seskvihidrata